Immunotherapy in the Peri-Operative Setting of HNSCC
3:45
Immunotherapy in the Peri-Operative Setting of HNSCC
181 viewsSep 26, 2017
YouTubeOncLive
Dr Weiss on Outcomes With Versamune HPV Plus Pembrolizumab in HPV16 HNSCC | OncLive
Dr Weiss on Outcomes With Versamune HPV Plus Pembrolizu…
Oct 14, 2024
onclive.com
Petosemtamab (MCLA-158) With Pembrolizumab as First-line (1L) Treatment of Recurrent/Metastatic (r/m) Head and Neck Squamous Cell Carcinoma (HNSCC): Phase 2 Study | OncLive
8:21
Petosemtamab (MCLA-158) With Pembrolizumab as First-line (1L) T…
Jun 16, 2024
onclive.com
Dr Uppaluri on the Implications of the FDA Approval of Perioperative Pembrolizumab in Resectable, Locally Advanced HNSCC | OncLive
Dr Uppaluri on the Implications of the FDA Approval of Perioperativ…
10 months ago
onclive.com
Pembrolizumab/carboplatin/paclitaxel combo shows antitumour activity in first-line recurrent/metastatic HNSCC - ecancer
Pembrolizumab/carboplatin/paclit…
501 viewsSep 14, 2022
ecancer.org
Dr Siu on the Rationale for Combining Petosemtamab With Pembrolizumab in HNSCC | OncLive
Dr Siu on the Rationale for Combining Petosemtamab With P…
Oct 4, 2024
onclive.com
Dr Perez on the Efficacy and Safety of Frontline Petosemtamab Plus Pembrolizumab in HNSCC | OncLive
2:09
Dr Perez on the Efficacy and Safety of Frontline Petosemtamab Plus P…
Aug 8, 2024
onclive.com
5:14
Emerging Evidence for Perioperative ICIs in Locally Adva…
9 months ago
reachmd.com
Petosemtamab (MCLA-158) With Pembrolizumab as First-Line (1L) …
11 months ago
onclive.com
4:01
Adjuvant Pembrolizumab Plus Cisplatin-Based Chemoradiation i…
7 months ago
reachmd.com
15:28
Global Perspectives on Perioperative Immunotherapy in L…
9 months ago
reachmd.com
Dr Adkins on the FDA Approval of Pembrolizumab for Neoadjuvant/A…
11 months ago
onclive.com
4:11
Dr Schmid on the Use of Perioperative Pembrolizumab in T…
Dec 8, 2023
onclive.com
1:05
Pembrolizumab KEYNOTE-689 Phase 3 Trial Update for LA-HNSC…
Apr 29, 2025
oncologytube.com
1:59
Dr Fayette on the Efficacy of Petosemtamab Plus Pembrolizum…
Jul 15, 2024
onclive.com
4:26
The Evolving Landscape of Resectable Locally Advanced HNS…
9 months ago
reachmd.com
13:42
Frontline Insights: Emerging Therapeutic Strategies in HNSCC
3 months ago
reachmd.com
Makoto Tahara, ESMO 2022: 5-year results from KEYNOTE-048 - Pem…
20 viewsSep 14, 2022
touchoncology.com
Petosemtamab Plus Pembrolizumab vs. Pembrolizumab Alone for Firs…
Sep 27, 2024
onclive.com
FDA approves Keytruda (pembrolizumab) and Keytruda Ql…
6 months ago
marketscreener.com
3:11
Important updates on locally advanced head and neck squamo…
657 viewsDec 27, 2020
FacebookESMO - European Society for Medical Oncology
2:08
ASPEN-03: evorpacept & pembrolizumab in unresectable, P…
26 views6 months ago
YouTubeVJOncology
1:42
Everett E. Vokes, MD, FASCO, from UChicago Medicine presents interi…
67 viewsJan 6, 2025
FacebookOncLive
11:45
Keynote 689#Perioperative Pembrolizumab#Immunotherapy#…
504 viewsMay 9, 2025
YouTubeCancer education made simple # Chandrakant…
3:04
ASPEN-04: evorpacept with pembrolizumab & chemotherapy i…
10 views6 months ago
YouTubeVJOncology
11:47
Pembrolizumab in HNSCC
654 viewsJul 10, 2017
YouTubeOncLive
2:30
Adjuvant Pembrolizumab Delivers Long-Term Benefits in ccRCC at I…
5 months ago
onclive.com
1:00
Perioperative Immunotherapy Breakthrough
1 month ago
YouTubeBackTable ENT
1:29
KEYNOTE-905: perioperative enfortumab vedotin and pembroliz…
91 views5 months ago
YouTubeVJOncology
5:24
KEYNOTE048: First line pembrolizumab for R/M HNSCC
90 viewsOct 29, 2018
YouTubeecancer
See more videos
Static thumbnail place holder